Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial Anis Rassi Jr, José Antonio Marin-Neto, Anis Rassi PAGE: 224-235 | DOI: 10.1590/0074-02760160334

Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach* Joseli Lannes-Vieira DOI: 10.1590/0074-02760220019